$5.42
0.48[9.72%]
At close: Apr 23
$5.42
0[0.00%]
After Hours: 6:46PM EDT
ImmunityBio
(NASDAQ:IBRX)ImmunityBio Stock (NASDAQ:IBRX), Quotes and News Summary
ImmunityBio Stock (NASDAQ: IBRX) stock price, news, charts, stock research, profile.
| Open | $6.150 |
| Close | $5.490 |
| Volume / Avg. | 30.658M / 4.223M |
| Day Range | 4.840 - 6.190 |
| 52 Wk Range | 1.250 - 6.930 |
| Market Cap | $3.669B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 38.97% |
| Days to Cover | 11.81 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About ImmunityBio Inc
Sector
Health Care
Industry
Biotechnology
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ImmunityBio (IBRX) stock?
You can purchase shares of ImmunityBio (NASDAQ: IBRX) through any online brokerage.
Who are ImmunityBio's (IBRX) competitors?
Other companies in ImmunityBio’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
What is the target price for ImmunityBio (IBRX) stock?
The latest price target for ImmunityBio (NASDAQ: IBRX) was reported by Piper Sandler on Monday, March 25, 2024. The analyst firm set a price target for 5.00 expecting IBRX to fall to within 12 months (a possible -7.75% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for ImmunityBio (IBRX)?
The stock price for ImmunityBio (NASDAQ: IBRX) is $5.42 last updated Today at April 23, 2024 at 6:46 PM EDT.
Does ImmunityBio (IBRX) pay a dividend?
There are no upcoming dividends for ImmunityBio.
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
ImmunityBio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is ImmunityBio (IBRX) going to split?
There is no upcoming split for ImmunityBio.
What sector and industry does ImmunityBio (IBRX) operate in?
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.